Back to Search
ELISE FELDMAN, PH.D.
PH.D.
Clinical Psychologist
NPI: 1871790279Individual
Specialties, Licenses & Credentials
Research & Publications (20)
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia.
PMID 18548095·Leukemia·2008
3-trial
Farnesyltransferase inhibitors in myelodysplastic syndrome.
PMID 15865870·Curr Hematol Rep·2005
6-review
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.
PMID 15961759·J Clin Oncol·2005
3-trial
Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195.
PMID 12592328·Leukemia·2003
3-trial
The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate.
PMID 12901975·Exp Hematol·2003
8-other
Commentary: dose intensive chemotherapy in acute myeloid leukemia.
PMID 11226517·Leuk Res·2001
8-other
High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia.
PMID 10739000·Leuk Res·2000
8-other
Patterning N-type and S-type neuroblastoma cells with Pluronic F108 and ECM proteins.
PMID 19609877·J Biomed Mater Res A·2010
7-preclinical
Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.
PMID 19592619·Diabetes·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 142 JORALEMON ST STE 720
BROOKLYN, NY 11201 - Phone
- (646) 470-9686
Quick Facts
- NPI
- 1871790279
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile